Lucid Group Appoints Former Pfizer R&D Leader Rod MacKenzie, CMG, PhD, as Board Chair to Drive Next Phase of Global Growth and Innovation
PR Newswire —
Appointment marks a pivotal step in Lucid's next phase of growth, strengthening its ability to translate complex science into real-world impact. Lucid's US Medical Affairs division unveils new proprietary insights tools to expand advisory capabilities. LONDON and PHILADELPHIA, March 18,...